Royalty Pharma
RPRX
#1003
Rank
NZ$33.10 B
Marketcap
$57.43
Share price
-0.79%
Change (1 day)
17.99%
Change (1 year)

Royalty Pharma (RPRX) - Cash on Hand

Cash on Hand as of December 2024 : NZ$3.10 Billion

According to Royalty Pharma's latest financial reports the company has NZ$3.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Royalty Pharma - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$3.14 B60.96%
2023-12-31NZ$1.95 B-48.98%
2022-12-31NZ$3.82 B-6.83%
2021-12-31NZ$4.10 B11.78%
2020-12-31NZ$3.67 B211.73%
2019-12-31NZ$1.17 B-66.89%
2018-12-31NZ$3.55 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.26 B-91.46%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.97 B 349.86%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.00 B 93.29%๐Ÿ‡บ๐Ÿ‡ธ USA